Vertex Pharmaceuticals | VRTX - Ebit



金融业
股票价格
USD 547.09
资产
USD 32.74B
现金及等价物
USD 6.3B
销售成本
USD 520.7M
流动资产
USD 11.69B
流动负债
USD 5B
债务
USD 1.98B
EBIT
USD 1.26B
EBITDA
USD 1.33B
员工
6.1K
EPS每股收益
USD 4.76
股本和储备
USD 20.91B
销售毛利
USD 2.94B
债务利息支出
USD 36M
利息收入
USD 120.6M
贷款资金
USD 3.5B
市值
USD 138.87B
净收入
USD 653.6M
营业费用
USD 2.18B
营业利润
USD 1.26B
普通股股本
USD 253.5M
PE价格收益
29.35
税前利润
USD 1.48B
销售收入
USD 3.44B
销售和管理费用
USD 556.3M
股票
USD 2.25B
贸易债权人
USD 3.71B
应收帐款人
USD 2.31B


Ebit 更改 日
AbbVie USD 6.88B 156M 2026-09
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
Arrowhead Research USD -154.34M 13.08M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD -707.47M 1.41B 2026-09
Insmed USD -81.83M 19.48M 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 6.47B 1B 2026-09
Merck USD 7.33B 6.49B 2026-09
Moderna USD 130M 945M 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
United Therapeutics USD 241.3M 134.3M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09